FDA Inspection 1201165 — Philosys Co. Ltd

Philosys Co. Ltd — FEI 3010172486

The FDA completed an inspection of Philosys Co. Ltd on March 30, 2023 in Gunsan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 30, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Gunsan (Korea (the Republic of))

Citations

IDCFRDescription
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
317521 CFR 820.186QSR